Trial Profile

REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction (RENAMI)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
Indications Acute coronary syndromes
Focus Adverse reactions

Most Recent Events

01 Apr 2019 Results assessing the incidence and predictors of ST after an acute coronary syndrome among patients receiving DAPT with ticagrelor vs prasugrel (n=4123) published in the Revista Espanola de Cardiologia
01 Mar 2019 Results assessing usefulness of the PARIS score to evaluate the ischemic-hemorrhagic net benefit with ticagrelor and prasugrel after an acute coronary syndrome published in the Revista Espanola de Cardiologia
14 Sep 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com